Risankizumab

MedChem Express

Risankizumab

10

Research Use Only

Monoclonal

99.37

Risankizumab (BI 655066) is a humanised IgG monoclonal antibody, targeting IL-23 p19 subunit ( K d 50 = 2 pM). Risankizumab can be used to research immunological and inflammatory disorders such as psoriasis vulgaris, psoriatic arthritis, generalized pustular psoriasis and erythrodermic psoriasis [1] [2] [3] .

-80°C

12352203